Plant Advanced Technologies (PAT) is a plant biotechnology company that produces rare and innovative active ingredients for the cosmetic, pharmaceutical, and agrochemical markets. The company develops proprietary extraction technologies and participates in collaborative research projects to supply high-value plant-based compounds while preserving biodiversity.
Subscribe to see PLANT ADVANCED’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
PLANT ADVANCED is a biotech company headquartered in France. Xcout tracks 2 named people at PLANT ADVANCED, including Jean-Paul Fèvre (Président / CEO).
A few of PLANT ADVANCED's closest competitors — see the full list of competitors and alternatives →
Emerald Health Bioceuticals Inc. develops biology-based life science solutions focused on enhancing human, animal, and plant life. The company utilizes advanced research, fermentation, biomanufacturing, and process development to create safe and sustainable products for its partners and customers.
Eggnovo is a biotechnology and ingredient development company specializing in high-value nutritional products derived from egg membranes.
Headquartered in Hanover, Germany, Phaeosynt is a biotechnology company founded to produce animal-free antibodies using diatoms instead of traditional methods.
Prairie Pharms, LLC produces small molecule plant extracts derived from monarda that contain a natural source of thymoquinone. The company serves the human health and companion pet markets by providing lipid-soluble and cell-permeable extracts for use in high-quality health products. Additionally, they seek business partners to develop innovative commercial products using their patented cultivation and extraction technologies.
Cannabinoid API Solutions, LLC provides hemp-derived cannabinoid active pharmaceutical ingredients, such as Cannabidiol (CBD) and Cannabigerol (CBG), for the pharmaceutical and nutraceutical industries. The company supplies ultra-pure and natural ingredients tailored for the CBD pharmaceutical market.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.